T. Braun

发表

Actionable perturbations of damage responses by TCL1/ATM and epigenetic lesions form the basis of T-PLL

S. Mustjoki, T. Haferlach, T. Brümmendorf, 2018, Nature Communications.

Advanced Pathogenetic Concepts in T-Cell Prolymphocytic Leukemia and Their Translational Impact

M. Seifert, M. Herling, T. Braun, 2021, Frontiers in Oncology.

JAK/STAT-Activating Genomic Alterations Are a Hallmark of T-PLL

R. Siebert, T. Aittokallio, S. Mustjoki, 2019, Cancers.

Advances and Perspectives in the Treatment of T-PLL

M. Herling, J. von Jan, T. Braun, 2020, Current Hematologic Malignancy Reports.

Noncanonical effector functions of the T-memory-like T-PLL cell are shaped by cooperative TCL1A and TCR signaling.

T. Aittokallio, D. Mougiakakos, M. Hallek, 2020, Blood.

The dawn of a new era in treating T-PLL

M. Herling, A. Schrader, T. Braun, 2019, Oncotarget.

Reinstated p53 response and high anti-T-cell leukemia activity by the novel alkylating deacetylase inhibitor tinostamustine

T. Aittokallio, S. Mustjoki, S. Timonen, 2020, Leukemia.

Blocking STAT3/5 through direct or upstream kinase targeting in leukemic cutaneous T‐cell lymphoma

C. Pirker, W. Berger, L. Cerroni, 2022, EMBO molecular medicine.

Exploration of whole genome and transcriptome sequencing data lacks evidence for oncogenic viral elements to drive the pathogenesis of T-cell prolymphocytic leukemia

R. Siebert, M. Schlesner, P. Lichter, 2022, Leukemia & lymphoma.

Actionable perturbations of damage responses by TCL1/ATM and epigenetic lesions form the basis of T-PLL

S. Mustjoki, T. Haferlach, T. Brümmendorf, 2018, Nature Communications.

Non-canonical function of AGO2 augments T-cell receptor signaling in T-cell prolymphocytic leukemia.

M. Hallek, M. Herling, J. Altmüller, 2022, Cancer research.

Single-cell characterization of leukemic and non-leukemic immune repertoires in CD8+ T-cell large granular lymphocytic leukemia

H. Lähdesmäki, S. Mustjoki, J. Maciejewski, 2022, Nature Communications.

Reconstruction of rearranged T‐cell receptor loci by whole genome and transcriptome sequencing gives insights into the initial steps of T‐cell prolymphocytic leukemia

S. Bens, R. Siebert, E. Campo, 2020, Genes, Chromosomes and Cancer.

Case Report: Large Granular Lymphocyte Leukemia (LGLL)—A Case Series of Challenging Presentations

M. Herling, U. Platzbecker, S. Schwind, 2022, Frontiers in Oncology.

Non-canonical effector functions of the T-memory-like T-PLL cell are shaped by cooperative TCL1A and TCR signaling.

T. Aittokallio, D. Mougiakakos, M. Hallek, 2020, Blood.

STAT3 Mutation Is Associated with STAT3 Activation in CD30+ ALK− ALCL

S. Mustjoki, P. Kovanen, P. Ellonen, 2020, Cancers.

Education and Empowering Special Forces to Eradicate Secret Defectors: Immune System-Based Treatment Approaches for Mature T- and NK-Cell Malignancies

A. Schrader, T. Braun, 2023, Cancers.

The miR-141/200c-STAT4 Axis Contributes to Leukemogenesis by Enhancing Cell Proliferation in T-PLL

T. Aittokallio, M. Hallek, J. Iqbal, 2023, Cancers.

Micro-RNA networks in T-cell prolymphocytic leukemia reflect T-cell activation and shape DNA damage response and survival pathways

M. Hallek, M. Herling, J. Altmüller, 2020, Haematologica.

Tracing the roots of CLPD-NK by TET2 and STAT3.

M. Herling, T. Braun, 2021, Blood.